Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 1
1948 5
1949 3
1950 9
1951 8
1952 20
1953 13
1954 17
1955 18
1956 23
1957 22
1958 17
1959 19
1960 18
1961 14
1962 22
1963 33
1964 52
1965 28
1966 38
1967 38
1968 38
1969 40
1970 31
1971 34
1972 27
1973 22
1974 25
1975 29
1976 18
1977 30
1978 39
1979 28
1980 41
1981 52
1982 60
1983 82
1984 79
1985 97
1986 94
1987 128
1988 118
1989 133
1990 159
1991 162
1992 162
1993 163
1994 179
1995 174
1996 209
1997 185
1998 204
1999 236
2000 275
2001 276
2002 324
2003 315
2004 332
2005 391
2006 404
2007 441
2008 408
2009 488
2010 488
2011 521
2012 508
2013 508
2014 576
2015 577
2016 550
2017 567
2018 587
2019 576
2020 596
2021 119
Text availability
Article attribute
Article type
Publication date

Search Results

12,252 results
Results by year
Filters applied: . Clear all
Page 1
Follicular lymphoma: 2020 update on diagnosis and management.
Freedman A, Jacobsen E. Freedman A, et al. Am J Hematol. 2020 Mar;95(3):316-327. doi: 10.1002/ajh.25696. Epub 2019 Dec 22. Am J Hematol. 2020. PMID: 31814159 Review.
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma is characterized by diffuse lymphadenopathy, bone marrow involvement, and splen …
DISEASE OVERVIEW: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed foll
Follicular lymphoma.
Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, López-Guillermo A, Fitzgibbon J. Carbone A, et al. Nat Rev Dis Primers. 2019 Dec 12;5(1):83. doi: 10.1038/s41572-019-0132-x. Nat Rev Dis Primers. 2019. PMID: 31831752 Review.
Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal centre (GC) B cell differentiation. FL represents ~5% of all haematological neoplasms and ~20-25% of all new non-Hodgkin lymphoma diagnoses in western countries. Tumori
Follicular lymphoma (FL) is a systemic neoplasm of the lymphoid tissue displaying germinal centre (GC) B cell differentiation.
Diagnosis and management of follicular lymphoma: A comprehensive review.
Dada R. Dada R. Eur J Haematol. 2019 Sep;103(3):152-163. doi: 10.1111/ejh.13271. Epub 2019 Jul 4. Eur J Haematol. 2019. PMID: 31270855 Review.
Follicular Lymphoma (FL) is an indolent lymphoma and may have various clinical courses. Worldwide, FL is the second most common non-Hodgkin lymphoma (NHL) type after diffuse large B-cell lymphoma. In this review article, the author is discussing
Follicular Lymphoma (FL) is an indolent lymphoma and may have various clinical courses. Worldwide, FL is the second mos
Recent landmark studies in follicular lymphoma.
Sorigue M, Sancho JM. Sorigue M, et al. Blood Rev. 2019 May;35:68-80. doi: 10.1016/j.blre.2019.03.006. Epub 2019 Mar 23. Blood Rev. 2019. PMID: 30928169 Review.
Follicular lymphoma (FL) is the most common indolent lymphoma. Therapeutic advances in the past decade have improved its prognosis, but some questions remain open, particularly over adapting therapy to each individual patient's disease risk. ...
Follicular lymphoma (FL) is the most common indolent lymphoma. Therapeutic advances in the past decade have improved it
[Follicular lymphoma: An update].
Sujobert P, Salles G. Sujobert P, et al. Presse Med. 2019 Jul-Aug;48(7-8 Pt 1):850-858. doi: 10.1016/j.lpm.2019.07.024. Epub 2019 Aug 22. Presse Med. 2019. PMID: 31447334 Review. French.
Follicular lymphoma, the second most common lymphoma, is characterized by its slow growth and is often considered incurable in advanced stages. ...Thanks to these advances, the median life expectancy of patients with follicular lymphoma now exce
Follicular lymphoma, the second most common lymphoma, is characterized by its slow growth and is often considered incur
Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet Needs.
Welaya K, Casulo C. Welaya K, et al. Hematol Oncol Clin North Am. 2019 Aug;33(4):627-638. doi: 10.1016/j.hoc.2019.03.003. Epub 2019 May 18. Hematol Oncol Clin North Am. 2019. PMID: 31229159 Review.
Follicular lymphoma is the most common indolent lymphoma in the United States. ...Patients with follicular lymphoma with unmet needs include those with early relapse, with multiple relapses, and with histologic transformation. ...
Follicular lymphoma is the most common indolent lymphoma in the United States. ...Patients with follicular ly
Pathology of follicular lymphoma.
Takata K, Miyata-Takata T, Sato Y, Yoshino T. Takata K, et al. J Clin Exp Hematop. 2014;54(1):3-9. doi: 10.3960/jslrt.54.3. J Clin Exp Hematop. 2014. PMID: 24942941 Free article. Review.
Follicular lymphoma (FL) is a heterogeneous disease, and there are many different subgroups, such as in terms of age of onset, involved organ (especially extranodal sites such as gastrointestinal tract) and genetic abnormality. ...In the 2008 WHO classification, thr
Follicular lymphoma (FL) is a heterogeneous disease, and there are many different subgroups, such as in terms of age of onset,
Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
Sugimoto T, Watanabe T. Sugimoto T, et al. J Clin Exp Hematop. 2016;56(1):1-19. doi: 10.3960/jslrt.56.1. J Clin Exp Hematop. 2016. PMID: 27334853 Free PMC article. Review.
The microenvironment of follicular lymphoma (FL) is composed of tumor-infiltrating CD8(+) T cells, follicular regulatory T cells, lymphoma-associated macrophages and mast cells, follicular helper T cells, follicular dendritic cells, and …
The microenvironment of follicular lymphoma (FL) is composed of tumor-infiltrating CD8(+) T cells, follicular regulator …
How I treat early-relapsing follicular lymphoma.
Casulo C, Barr PM. Casulo C, et al. Blood. 2019 Apr 4;133(14):1540-1547. doi: 10.1182/blood-2018-08-822148. Epub 2019 Jan 30. Blood. 2019. PMID: 30700421 Review.
Follicular lymphoma (FL) is the most frequently occurring indolent non-Hodgkin lymphoma, with generally favorable outcomes but a variable clinical course. ...
Follicular lymphoma (FL) is the most frequently occurring indolent non-Hodgkin lymphoma, with generally favorable outco
Toward a Cure for Follicular Lymphoma.
Friedberg JW. Friedberg JW. Hematol Oncol Clin North Am. 2020 Aug;34(4):xiii-xiv. doi: 10.1016/j.hoc.2020.05.001. Epub 2020 May 20. Hematol Oncol Clin North Am. 2020. PMID: 32586582 No abstract available.
12,252 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page